OLD Category: immunology

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

• Marks DK, Gartrell RD, El Asmar M...Connolly E, Saenger Y, Kalinsky K

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors

• Albershardt TC, Leleux J, Parsons AJ, Krull JE, Berglund P, ter Meulen J

Resolving Metabolic Heterogeneity in Experimental Models of the Tumor Microenvironment from a Stable Isotope Resolved Metabolomics Perspective

• Fan TW-M, Higashi RM, Chernayavskaya Y, Lane AN

Distinct Features of Human Myeloid Cell Cytokine Response Profiles Identify Neutrophil Activation by Cytokines as a Prognostic Feature during Tuberculosis and Cancer

• Devlin JC, Zwack EE, Tang MS, Li Z, Fenyo D, Torres VJ, Ruggles KV, Loke P.

Piperlongumine Acts as an Immunosuppressant by Exerting Prooxidative Effects in Human T Cells Resulting in Diminished TH17 but Enhanced Treg Differentiation

• Liang J, Ziegler JD, Jahraus B...Hübner K, Balta E, Samstag Y

Lung Function and Gene Expression of Pathogen Recognition Pathway Receptors: the Cardia Lung Study

• Ramasubramanian R, Kalhan R, Jacobs DR Jr, Washko GR, Hou L, Gross MD, Guan W, Thyagarajan B.

Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma

• Choi KU, Kim A, Kim JY, Kim KH, Hwang C, Lee SJ, Park WY, Jung S, Choi HJ, Kim K.

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

• Lozano E, Mena MP, Díaz T, Prat A, Rosinol L, Fernández de Larrea C

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA

• Sehn LH, Martelli M, Trněný M, Liu W, Bolen CR, Knapp A, Sahin D, Sellam G, Vitolo U.

DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer

• de Cubas AA, Dunker W, Zaninovich A...Ganesan S, Karijolich J, Rathmell WK

Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo

• Boukhedouni N, Martins C, Darrigade AS...Bernard FX, Seneschal J, Boniface K

Immune Landscapes Predict Chemotherapy Resistance and Immunotherapy Response in Acute Myeloid Leukemia

• Vadakekolathu J, Minden MD, Hood T, Church SE, Reeder S, Altmann H, Sullivan AH, Viboch EJ, Patel T, Ibrahimova N, Warren SE, Arruda A, Liang Y, Smith TH, Foulds GA, Bailey MD, Gowen-MacDonald J, Muth J, Schmitz M, Cesano A, Pockley AG, Valk PJM, Löwenberg B, Bornhäuser M, Tasian SK, Rettig MP, Davidson-Moncada JK, DiPersio JF, Rutella S